<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002870'>Obstructive sleep apnea</z:hpo> (OSA) is associated with <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> and mortality, largely as a result of myocardial anomalies </plain></SENT>
<SENT sid="1" pm="."><plain>Numerous mechanisms cause OSA-related myocardial damage </plain></SENT>
<SENT sid="2" pm="."><plain>The majority are initiated as a result of OSA-induced, <z:hpo ids='HP_0011010'>chronic</z:hpo>, intermittent <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The most-important mechanisms that lead to myocardial damage are increased sympathetic activity, <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, systemic <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and metabolic anomalies </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these mechanisms promote the development of <z:hpo ids='HP_0000822'>hypertension</z:hpo>, which is common in patients with OSA </plain></SENT>
<SENT sid="5" pm="."><plain>Hypertensive <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>, as well as <z:hpo ids='HP_0001513'>obesity</z:hpo>-related, diabetic, and <z:hpo ids='HP_0001649'>tachycardia</z:hpo>-induced <z:hpo ids='HP_0001638'>cardiomyopathies</z:hpo>, are also associated with OSA </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001712'>Left ventricular hypertrophy</z:hpo>, <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo>, atrial <z:mpath ids='MPATH_66'>dilatation</z:mpath>, and left ventricular systolic and diastolic dysfunction in patients with OSA explain the association of the disease with these clinical outcomes </plain></SENT>
<SENT sid="7" pm="."><plain>The gold-standard treatment for OSA, nasal continuous positive airway pressure (CPAP), might improve cardiac symptoms and hemodynamic parameters in patients with the disease </plain></SENT>
<SENT sid="8" pm="."><plain>However, large clinical trials are required to improve our understanding of the cardiac consequences of OSA, and determine the effect of treatment, particularly CPAP, on myocardial damage in symptomatic patients and primary prevention of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disorders</z:e> </plain></SENT>
</text></document>